Essay - Pfizer SWOT Pfizer—a SWOT Analysis Strengths Pfizer is One of...


1 2
Copyright Notice

Pfizer SWOT

Pfizer—a SWOT Analysis

Strengths

Pfizer is one of the world's leading research pharmaceutical companies and also one of the ***** most profitable *****. It has a well-respected name known all over the world and commands some of the top research, advertising, financial, and marketing talent. It produces two of the most well-known name-brand drugs, Viagra and Lipitor in America today. Even the American Heart Association recommends the use of drugs such as Lipitor to reduce cholesterol when diet ***** exercise fail ***** reduce this common health problem. High cholesterol as a common health problem is only likely to *****cre*****e with the rapidly aging population—and the rise in obesity levels (Berenson, 2007).

*****

Unfortunately, "while the company remains highly profitable, its ***** health is increasingly tied ***** Lipitor" which is dangerous for the company in ***** future as Lipitor's patent will expire in several years, which means it ***** face competition from cheaper, generic ***** (*****, 2007). Pfizer's reputation has also been ta*****ted by its association with Celebrex, a pain medication that has been tied to increased risk of heart problems, in comparison to over-the-counter painkillers. The prominence ***** the Pfizer advertising campaign for ***** drug, followed by ***** rapid fall from grace undoubtedly damaged the company's trusted name.

Pfizer ***** manufactures Zoloft, an antidepressant that was widely criticized for its over-prescription to teenager, and possibly causing ***** suicidal thoughts in this population. ***** company website now states that the drug is not advised for people under the age of 17. Antidepressants ***** 'lifestyle' *****s like Viagra have come under *****creased media scrutiny and used as examples of the over-prescription of medication in ***** American *****care system ***** general. Healthcare in America is growing more and more expensive, and insurance companies are being pressured to cut costs, including scaling back how much they pay ***** drugs.

*****, Exubera, "the first ***** so far ***** commercially available inhaled-insulin diabetes treatment," is on the verge ***** turning in***** an "expensive failure" as Pfizer "***** been dogged by questions about its safety, cost and convenience" (Berenson, 2007).

Opportunities

According to the Pfizer press release section of its website, discomfort associated with fibromyaglia, a common chronic pain condition, has ***** s*****n ***** be significantly reduced by a new drug developed by ***** called Lyrica, "according to study results presented ***** at the ***** Academy of Neurology annual meeting" ("Lyrica Significantly Reduced Pain," 2007, Press Release). Pfizer has also developed a new AIDS ***** ***** Maraviroc, which is likely to considerably improve ***** extend the life ***** AIDS patients who take the drug, ***** ***** researchers at ***** University of Pittsburg and Columbia University (Altman & Pollock, 2007).

Threats

Both Merck and Schering-Plough, ***** of Pfizer's greatest rivals, plan to combine forces ***** develop a medicine ***** rival Lipitor. "The planned drug, meant to reduce levels of the harmful type of cholesterol in two ways, could hit ***** market when ***** patent expires in a few *****" ("Merck and Schering-Plough Plan Another Cholesterol Drug,"

. . . . [END OF TERM PAPER PREVIEW]

Download entire paper (and others like it)    |    Order a brand new, custom paper

Other topics that might interest you:

© 2001–2017   |   Book Report about Pfizer SWOT Pfizer—a SWOT Analysis Strengths Pfizer is One of   |   Term Papers Models